CN100508968C - 减轻应激、焦虑和进攻性的禽平息信息素 - Google Patents

减轻应激、焦虑和进攻性的禽平息信息素 Download PDF

Info

Publication number
CN100508968C
CN100508968C CNB038172968A CN03817296A CN100508968C CN 100508968 C CN100508968 C CN 100508968C CN B038172968 A CNB038172968 A CN B038172968A CN 03817296 A CN03817296 A CN 03817296A CN 100508968 C CN100508968 C CN 100508968C
Authority
CN
China
Prior art keywords
isomers
composition
acid
alcohols
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038172968A
Other languages
English (en)
Chinese (zh)
Other versions
CN1668318A (zh
Inventor
P·帕雅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fideline
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Publication of CN1668318A publication Critical patent/CN1668318A/zh
Application granted granted Critical
Publication of CN100508968C publication Critical patent/CN100508968C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
CNB038172968A 2002-06-19 2003-06-19 减轻应激、焦虑和进攻性的禽平息信息素 Expired - Fee Related CN100508968C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
US60/389,768 2002-06-19
EP02291533.4 2002-06-19
EP02291533 2002-06-19

Publications (2)

Publication Number Publication Date
CN1668318A CN1668318A (zh) 2005-09-14
CN100508968C true CN100508968C (zh) 2009-07-08

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038172968A Expired - Fee Related CN100508968C (zh) 2002-06-19 2003-06-19 减轻应激、焦虑和进攻性的禽平息信息素

Country Status (12)

Country Link
EP (1) EP1531839B1 (https=)
JP (1) JP4863619B2 (https=)
CN (1) CN100508968C (https=)
AT (1) ATE468123T1 (https=)
AU (1) AU2003246372B8 (https=)
BR (1) BRPI0311934B1 (https=)
CA (1) CA2490681C (https=)
DK (1) DK1531839T3 (https=)
ES (1) ES2345099T3 (https=)
MX (1) MXPA04013005A (https=)
PT (1) PT1531839E (https=)
WO (1) WO2004000336A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109475104A (zh) * 2016-06-15 2019-03-15 韦尔维克-贝拉维公司 信息素组合物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629286B2 (ja) * 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
AU2016221929A1 (en) * 2015-02-20 2017-07-13 Société des Produits Nestlé S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
EP3727457B1 (fr) 2017-12-22 2025-08-20 Ceva Santé Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
JP4754688B2 (ja) * 1998-01-21 2011-08-24 フィドゥラン ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
DK1382343T3 (da) * 1998-11-02 2010-04-26 Gilead Sciences Inc Kombinationsterapi til behandling af hepatitis B-virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077867A (en) * 1998-01-21 2000-06-20 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
US6169113B1 (en) * 1998-01-21 2001-01-02 Patrick Pageat Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
CN1291093A (zh) * 1998-01-21 2001-04-11 菲德利尼公司 可减轻应激、焦虑和进攻性的猪平息信息素

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109475104A (zh) * 2016-06-15 2019-03-15 韦尔维克-贝拉维公司 信息素组合物
CN109475104B (zh) * 2016-06-15 2021-09-28 韦尔维克-贝拉维公司 信息素组合物

Also Published As

Publication number Publication date
AU2003246372B8 (en) 2009-03-26
DK1531839T3 (da) 2010-09-13
JP2006508038A (ja) 2006-03-09
BR0311934A (pt) 2005-04-05
BRPI0311934B1 (pt) 2015-05-26
CA2490681C (en) 2012-01-24
CN1668318A (zh) 2005-09-14
ATE468123T1 (de) 2010-06-15
EP1531839A1 (en) 2005-05-25
WO2004000336A1 (en) 2003-12-31
EP1531839B1 (en) 2010-05-19
PT1531839E (pt) 2010-07-21
JP4863619B2 (ja) 2012-01-25
AU2003246372B2 (en) 2008-11-27
MXPA04013005A (es) 2005-09-12
CA2490681A1 (en) 2003-12-31
AU2003246372A1 (en) 2004-01-06
ES2345099T3 (es) 2010-09-15

Similar Documents

Publication Publication Date Title
JP4750232B2 (ja) ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
Ros et al. The relation among gonadal steroids, immunocompetence, body mass, and behavior in young black-headed gulls (Larus ridibundus)
US9844217B2 (en) Allomone repulsive and kairomone attractive compositions for controlling arachnids
Nicol et al. Farmed bird welfare science review
EP4294204A1 (en) Methods of selectively promoting animal welfare through modulation of microbiome
CN100508968C (zh) 减轻应激、焦虑和进攻性的禽平息信息素
US7723388B2 (en) Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
JP4754688B2 (ja) ストレス、不安及び攻撃性を低減するブタ鎮静フェロモン
Yonezawa et al. Appeasing pheromone inhibits cortisol augmentation and agonistic behaviors during social stress in adult miniature pigs
Richard-Yris et al. Effects of exposure to chicks on maternal behaviour in domestic chickens
BR112014032323B1 (pt) semioquímicos para marcação de arranhadura de felinos
Yu Culicoides hypersensitivity: therapy
Edwards et al. Stress, Well-Being, and Reproduction in Wildlife
Nelson et al. The influence of season, photoperiod, and pineal
Lonardi PAIN ASSESSMENT METHODS: THE CASE OF SURGICAL CASTRATION IN PIGLETS
Leistner The Effect of Prophylactic Homoeopathic Treatment of Gallus gallus domesticus, Ross Hybrid, in Broiler Farming, in Conditions of Stress and Aspergillosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090708

Termination date: 20200619

CF01 Termination of patent right due to non-payment of annual fee